Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,536.00
+26.00 (1.72%)
At close: Dec 5, 2025
Gencurix Market Cap
Gencurix has a market cap or net worth of 24.76 billion as of December 5, 2025. Its market cap has decreased by -30.45% in one year.
Market Cap
24.76B
Enterprise Value
27.36B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,536.00
Market Cap Chart
Since April 5, 2017, Gencurix's market cap has decreased from 73.36B to 24.76B, a decrease of -66.25%. That is a compound annual growth rate of -11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 24.76B | -17.56% |
| Dec 30, 2024 | 30.03B | -64.40% |
| Dec 28, 2023 | 84.35B | 82.80% |
| Dec 29, 2022 | 46.15B | -60.69% |
| Dec 30, 2021 | 117.40B | 11.19% |
| Dec 30, 2020 | 105.58B | 18.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8.91T |
| LigaChem Biosciences | 7.14T |
| Peptron | 6.67T |